Holen Sie sich die Stockscreener-App
215.53
2.03%
4.28
Schlusskurs vom Vortag:
$211.25
Offen:
$211.76
24-Stunden-Volumen:
1.00M
Relative Volume:
0.80
Marktkapitalisierung:
$30.06B
Einnahmen:
$2.12B
Nettoeinkommen (Verlust:
$-309.19M
KGV:
-94.36
EPS:
-2.2841
Netto-Cashflow:
$93.57M
1W Leistung:
+1.44%
1M Leistung:
-6.80%
6M Leistung:
+33.74%
1J Leistung:
+27.25%
1-Tages-Spanne:
$210.57
$220.65
1-Wochen-Bereich:
$204.04
$220.65
52-Wochen-Spanne:
$125.38
$256.36
Natera Inc Stock (NTRA) Company Profile
Firmenname
Natera Inc
Sektor
Branche
Telefon
650-249-9090
Adresse
13011 MCCALLEN PASS, AUSTIN, CA
Compare NTRA vs TMO, DHR, IDXX, A, WAT
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
NTRA
Natera Inc
|
215.53 | 29.46B | 2.12B | -309.19M | 93.57M | -2.2841 |
|
TMO
Thermo Fisher Scientific Inc
|
513.56 | 188.45B | 44.56B | 6.73B | 6.29B | 17.74 |
|
DHR
Danaher Corp
|
208.56 | 145.88B | 24.57B | 3.60B | 5.25B | 5.0475 |
|
IDXX
Idexx Laboratories Inc
|
634.90 | 50.00B | 4.30B | 1.06B | 1.04B | 13.08 |
|
A
Agilent Technologies Inc
|
126.94 | 35.04B | 6.95B | 1.30B | 1.15B | 4.5696 |
|
WAT
Waters Corp
|
327.53 | 31.53B | 3.17B | 642.63M | 539.81M | 10.77 |
Natera Inc Stock (NTRA) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-01-07 | Eingeleitet | Citigroup | Buy |
| 2025-12-02 | Fortgesetzt | Morgan Stanley | Overweight |
| 2025-10-27 | Hochstufung | BNP Paribas Exane | Underperform → Neutral |
| 2025-09-22 | Fortgesetzt | Wells Fargo | Equal Weight |
| 2025-03-13 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2025-01-23 | Eingeleitet | Barclays | Overweight |
| 2024-06-03 | Fortgesetzt | Jefferies | Buy |
| 2024-04-08 | Fortgesetzt | Craig Hallum | Buy |
| 2024-02-20 | Herabstufung | Raymond James | Strong Buy → Outperform |
| 2023-12-29 | Bestätigt | BTIG Research | Buy |
| 2023-12-14 | Eingeleitet | Guggenheim | Buy |
| 2023-12-13 | Eingeleitet | Wolfe Research | Outperform |
| 2023-11-13 | Hochstufung | Raymond James | Outperform → Strong Buy |
| 2023-09-28 | Eingeleitet | Bernstein | Mkt Perform |
| 2023-07-05 | Fortgesetzt | JP Morgan | Overweight |
| 2023-05-05 | Eingeleitet | UBS | Buy |
| 2023-01-18 | Hochstufung | Raymond James | Mkt Perform → Outperform |
| 2022-08-25 | Eingeleitet | Credit Suisse | Outperform |
| 2022-04-25 | Eingeleitet | Stephens | Overweight |
| 2022-03-08 | Eingeleitet | Goldman | Buy |
| 2022-01-06 | Fortgesetzt | Piper Sandler | Overweight |
| 2021-10-15 | Fortgesetzt | Cowen | Outperform |
| 2021-06-15 | Eingeleitet | Raymond James | Mkt Perform |
| 2021-05-25 | Eingeleitet | Wells Fargo | Overweight |
| 2021-01-28 | Eingeleitet | Truist | Buy |
| 2020-10-08 | Eingeleitet | BTIG Research | Buy |
| 2020-09-28 | Eingeleitet | Morgan Stanley | Overweight |
| 2020-09-17 | Eingeleitet | SVB Leerink | Outperform |
| 2020-06-10 | Fortgesetzt | Piper Sandler | Overweight |
| 2020-05-07 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2018-10-05 | Eingeleitet | JP Morgan | Neutral |
| 2018-07-05 | Bestätigt | Piper Jaffray | Overweight |
| 2017-08-07 | Bestätigt | Morgan Stanley | Overweight |
| 2016-11-10 | Bestätigt | The Benchmark Company | Buy |
| 2016-05-23 | Bestätigt | The Benchmark Company | Buy |
| 2016-05-11 | Bestätigt | The Benchmark Company | Buy |
| 2016-04-19 | Eingeleitet | The Benchmark Company | Buy |
| 2015-09-28 | Hochstufung | Wedbush | Neutral → Outperform |
| 2015-08-14 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2015-08-04 | Eingeleitet | Robert W. Baird | Outperform |
| 2015-07-27 | Eingeleitet | Morgan Stanley | Equal-Weight |
| 2015-07-27 | Eingeleitet | Piper Jaffray | Overweight |
| 2015-07-27 | Eingeleitet | Wedbush | Neutral |
Alle ansehen
Natera Inc Aktie (NTRA) Neueste Nachrichten
Assessing Natera (NTRA) Valuation After Launch Of EDEN Preeclampsia Risk Study - simplywall.st
Natera Accuses Worker Who Went to Competitor of Stealing Secrets - Bloomberg Law News
Analysts Offer Insights on Healthcare Companies: American Well (AMWL), Centene (CNC) and Natera (NTRA) - The Globe and Mail
Natera, Inc. $NTRA Shares Sold by Eagle Health Investments LP - MarketBeat
Readystate Asset Management LP Invests $12.74 Million in Natera, Inc. $NTRA - MarketBeat
Piper Sandler reiterates Natera stock rating on Japan expansion - Investing.com
Natera to Report its Fourth Quarter and Full Year Results on February 26, 2026 - Yahoo Finance
Zweig DiMenna Associates LLC Buys 8,400 Shares of Natera, Inc. $NTRA - MarketBeat
JPMorgan Chase & Co. Buys 1,003,129 Shares of Natera, Inc. $NTRA - MarketBeat
Natera's Signatera test to be covered under Medicare - MSN
Natera, Inc. (NTRA) Stock Analysis: Unpacking the 24.72% Potential Upside in the Diagnostics Powerhouse - DirectorsTalk Interviews
Natera, Inc. (NTRA) reports preliminary Q4 revenue - MSN
How (NTRA) Movements Inform Risk Allocation Models - Stock Traders Daily
CareDx Seeks High Court Review Of $45M False Ad Case - Law360
Prenatal Testing Co. Missed Fatal Condition, Couple Say - Law360
Krilogy Financial LLC Takes Position in Natera, Inc. $NTRA - MarketBeat
Allspring Growth Fund Q4 2025 Fund Performers And Detractors - Seeking Alpha
Envestnet Asset Management Inc. Purchases 17,254 Shares of Natera, Inc. $NTRA - MarketBeat
How Natera Inc. stock trades before earnings2025 Dividend Review & Real-Time Buy Signal Notifications - mfd.ru
Natera Inc (NTRA) Trading 3.93% Higher on Feb 9 - GuruFocus
When Will Natera, Inc. (NASDAQ:NTRA) Breakeven? - 富途牛牛
Earnings Miss: What are analysts price targets for Natera Inc2025 Market Overview & Pattern Based Trade Signal System - baoquankhu1.vn
Natera, Inc. $NTRA Shares Sold by Savant Capital LLC - MarketBeat
Is Natera (NTRA) Quietly Redefining Its Moat With Multi-Front Cell-Free DNA Expansion? - simplywall.st
IQ EQ FUND MANAGEMENT IRELAND Ltd Boosts Holdings in Natera, Inc. $NTRA - MarketBeat
Natera Launches EDEN Study on Early Risk Assessment for Preeclampsia and Adverse Pregnancy Outcomes - Yahoo Finance
AGF Management Ltd. Sells 6,300 Shares of Natera, Inc. $NTRA - MarketBeat
This brand-new Peninsula building sat vacant for a year. Now it's landed two big tenants - The Business Journals
News | Genetic testing firm inks deal at Silicon Valley life science campus - CoStar
C WorldWide Group Holding A S Decreases Stock Position in Natera, Inc. $NTRA - MarketBeat
Natera, Inc. $NTRA Shares Purchased by Thrivent Financial for Lutherans - MarketBeat
Natera CEO sells $20.7 million in NTRA stock By Investing.com - Investing.com South Africa
Natera sec. and chief legal officer sells $307k in stock By Investing.com - Investing.com Nigeria
Natera sec. and chief legal officer sells $307k in stock - Investing.com UK
Natera director Sheena Jonathan sells $100k in stock By Investing.com - Investing.com Australia
Natera (NASDAQ:NTRA) CEO Steven Leonard Chapman Sells 4,725 Shares - MarketBeat
Natera (NASDAQ:NTRA) Insider Sells $378,232.03 in Stock - MarketBeat
Solomon Moshkevich Sells 3,000 Shares of Natera (NASDAQ:NTRA) Stock - MarketBeat
Natera files Signatera CDx PMA with FDA for bladder cancer MRD test - MSN
Natera CFO Brophy sells $1.58 million in NTRA stock By Investing.com - Investing.com Canada
Natera Inc: President Moshkevich sells $1.07 million in NTRA stock By Investing.com - Investing.com Nigeria
Natera (NASDAQ:NTRA) Insider Sells $830,285.88 in Stock - MarketBeat
Natera Inc. president Fesko sells $830k in stock By Investing.com - Investing.com Nigeria
Natera CEO sells $20.7 million in NTRA stock - Investing.com
Natera Inc: President Moshkevich sells $1.07 million in NTRA stock - Investing.com
Oversold Conditions For Natera (NTRA) - Nasdaq
Natera Inc (NTRA) Stock Price Down 7.82% on Feb 4 - GuruFocus
Principal Financial Group Inc. Has $69.11 Million Stake in Natera, Inc. $NTRA - MarketBeat
National Pension Service Invests $1.49 Million in Natera, Inc. $NTRA - MarketBeat
Trading Systems Reacting to (NTRA) Volatility - Stock Traders Daily
Natera Files Signatera CDx PMA With FDA for Bladder Cancer MRD Test - The Globe and Mail
Finanzdaten der Natera Inc-Aktie (NTRA)
Umsatz
Nettogewinn
Free Cashflow
ENV
4.03%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):